Skip to content

CDR

Wasson: Walgreens’ strategy ‘blurs retail channels’

Wasson: Walgreens’ strategy ‘blurs retail channels’

With a much-publicized PBM battle now behind it, Walgreen Co. is locked in on expanding its "Well Experience" health and daily living strategy across its stores and other channels, president and chief executive officer Greg Wasson told attendees at the company’s annual shareholder meeting.

Macy’s CEO joins P&G board

Terry Lundgren, chairman, president and chief executive officer of Macy’s Inc., has been named to the board of directors of Procter & Gamble Co.

NPC examines CER as health reform takes hold

By the close of 2012 two key questions regarding the Affordable Care Act were finally addressed: one, whether the health care reform law is constitutional and, two, whether it would be repealed under a new administration.

2013 Outlook: Retail Rx embraces change

2013 Outlook: Retail Rx embraces change

Chain drug executives are sounding an upbeat tone as they size up their prospects for 2013. Though most executives express concern about fiscal developments in Washington, they are confident in the outlook for the retail pharmacy industry.

Rite Aid’s Thompson honored as top pharmacy exec

Rite Aid’s Thompson honored as top pharmacy exec

For his leadership in marshalling his team and executing a well-thought-out pharmacy plan, Rite Aid Corp. executive vice president of pharmacy Robert Thompson has been named Pharmacy Executive of the Year by Chain Drug Review. Pharmacists at Rite Aid are making a bigger commitment to health care.

Sanofi’s Chattem acquires Rolaids

Chattem Inc., the U.S. consumer health division of Sanofi, has completed the acquisition of the worldwide rights to the Rolaids antacid brand from the McNeil Consumer Healthcare Division of McNeil-PPC Inc.

Boehringer Ingelheim tool helps improve Rx adherence

Just as no two patients are alike, no single strategy should serve as the approach to improving medication adherence. That’s one of the principles behind the Patient Empowerment Program (PEP) that can be used by pharmacists to help improve compliance.

<i>CDR</i> names Wasson, Pessina Retailers of Year

When the editors of Chain Drug Review looked back at 2012 with an eye toward identifying the executives who had the biggest impact on the industry, one event and the people behind it clearly stood out: the unprecedented partnership Walgreen Co.